ABO-incompatible deceased donor liver transplantation with the use of antigen-specific immunoadsorption and anti-CD20 monoclonal antibody

被引:24
作者
Boberg, KM [1 ]
Foss, A
Midtvedt, K
Schrumpf, E
机构
[1] Natl Hosp Norway, Dept Med, N-0027 Oslo, Norway
[2] Natl Hosp Norway, Dept Surg, N-0027 Oslo, Norway
关键词
fulminant liver failure; humoral rejection; rituximab;
D O I
10.1111/j.1399-0012.2005.00470.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
In patients with fulminant liver failure requiring emergency liver transplantation, the only donor organ that becomes available may be ABO incompatible. The risk of graft failure because of antibody-mediated acute rejection is high, but can be reduced by various means. We reported a deceased donor ABO-incompatible liver allograft recipient who was treated with antigen-specific immunoadsorption in combination with anti-CD20 monoclonal antibody and conventional plasmapheresis and immunosuppression. The patient was a 33-yr-old male with blood group A who presented with subacute liver failure of unknown aetiology and received a blood group AB liver graft. Pretransplant he underwent plasmapheresis and received one dose of rituximab. The immunosuppressive regimen consisted of methylprednisolone, tacrolimus and mycophenolate mofetil. Despite regular post-operative plasmapheresis sessions, anti-B antibody titres increased. Antigen-specific immunoadsorption with depletion of anti-B antibodies was performed from day nine to day 17. Thereafter, anti-B IgM and IgG antibody titres remained low. After one month the patient was reoperated with hepaticojejunostomy because of bile duct necrosis and with reconstruction of a stenotic hepatic artery. A mild rejection was successfully treated with methylprednisolone four months post-transplant. At six months post-transplant there was a stricture of the biliary-enteric anastomosis, but the graft was well functioning. We conclude that antigen-specific immunoadsorption can be an important adjuvant therapy to control recipient anti-A/B antibody levels and prevent acute rejection in ABO-incompatible deceased donor liver transplantation.
引用
收藏
页码:265 / 268
页数:4
相关论文
共 48 条
  • [21] ABO-incompatible deceased donor pediatric liver transplantation: Novel titer-based management protocol and outcomes
    Mysore, Krupa R.
    Himes, Ryan W.
    Rana, Abbas
    Teruya, Jun
    Desai, Moreshwar S.
    Srivaths, Poyyapakkam R.
    Zaruca, Kimberly
    Calvert, Andrea
    Guffey, Danielle
    Minard, Charles G.
    Morita, Eda
    Hensch, Lisa
    Losos, Michael
    Kostousov, Vadim
    Hui, Shiu-Ki Rocky
    Orange, Jordan S.
    Goss, John A.
    Nicholas, Sarah K.
    PEDIATRIC TRANSPLANTATION, 2018, 22 (07)
  • [22] The fate of donor-type ABO blood group antigen expression in liver grafts in ABO-incompatible adult living donor liver transplantation
    Oh, Moon Young
    Kim, Haeryoung
    Yi, Nam-Joon
    Hong, Suyoung
    Lee, Jeong-Moo
    Lee, Sola
    Hong, Suk Kyun
    Choi, YoungRok
    Lee, Kwang-Woong
    Suh, Kyung-Suk
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2023, 30 (07) : 871 - 881
  • [23] Seroconversion of red blood cell antibody in ABO-incompatible living donor liver transplantation -a case report
    Lee, Eun Kyung
    Song, Insun
    Kim, Gaab Soo
    KOREAN JOURNAL OF ANESTHESIOLOGY, 2020, 73 (03) : 252 - 256
  • [24] Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysis
    Wilpert, Jochen
    Fischer, Karl-Georg
    Pisarski, Przemyslaw
    Wiech, Thorsten
    Daskalakis, Michael
    Ziegler, Anna
    Neumann-Haefelin, Elke
    Drognitz, Oliver
    Emmerich, Florian
    Walz, Gerd
    Geyer, Marcel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (11) : 3778 - 3786
  • [25] The Excellent Outcomes of ABO-Incompatible Kidney Transplantation With High Titer (>x2048) Using Anti-CD20 and Anti-CD25 Antibody Without Splenectomy: Two Case Reports
    Koshino, K.
    Okamoto, M.
    Sakai, K.
    Suzuki, T.
    Nobori, S.
    Matsuyama, M.
    Ushigome, H.
    Okajima, H.
    Yoshimura, N.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (06) : 2379 - 2382
  • [26] An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab
    Boye, J
    Elter, T
    Engert, A
    ANNALS OF ONCOLOGY, 2003, 14 (04) : 520 - 535
  • [27] Clinical course and pathologic findings of successful second ABO-incompatible renal transplantation in a patient with donor-specific anti-HLA antibody
    Saito, Mitsuru
    Satoh, Shigeru
    Inoue, Takamitsu
    Yuasa, Takeshi
    Komatsuda, Atsushi
    Tsuchiya, Norihiko
    Habuchi, Tomonori
    CLINICAL TRANSPLANTATION, 2007, 21 : 54 - 59
  • [28] Use of ABO-incompatible grafts in living donor liver transplantation--first report from India.
    Soin A.S.
    Raut V.
    Mohanka R.
    Rastogi A.
    Goja S.
    Balachandran M.
    Saigal S.
    Saraf N.
    Bhangui P.
    Sumana K.R.
    Singla P.
    Srinivasan T.
    Choudhary N.
    Tiwari A.
    Raina V.
    Govil D.
    Mohan N.
    Vohra V.
    Indian Journal of Gastroenterology, 2014, 33 (1) : 72 - 76
  • [29] Stratified Analysis of Survival Benefit for ABO-incompatible Deceased-donor Liver Transplantation: Multicenter Propensity Score-matched Study
    Yang, Mengfan
    Wei, Xuyong
    Khan, Abdul Rehman
    Wei, Qiang
    Wang, Rui
    Pan, Binhua
    Wang, Kun
    Zhou, Zhisheng
    Lu, Di
    Cen, Beini
    Zhang, Shuijun
    Guo, Wenzhi
    Zheng, Shusen
    Yang, Yang
    Xu, Xiao
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2023, 11 (04) : 827 - 838
  • [30] Antibody-mediated rejection after ABO-incompatible pediatric living donor liver transplantation for propionic acidemia: A case report
    Honda, Masaki
    Sakamoto, Seisuke
    Sakamoto, Rieko
    Matsumoto, Shirou
    Irie, Tomoaki
    Uchida, Koushi
    Shimata, Keita
    Kawabata, Seiichi
    Isono, Kaori
    Hayashida, Shintaro
    Yamamoto, Hidekazu
    Endo, Fumio
    Inomata, Yukihiro
    PEDIATRIC TRANSPLANTATION, 2016, 20 (06) : 840 - 845